Back to search

McMaster University

Allosteric Rewiring and Pharmacological Modulation of Protein Kinase G

Abstract

dc:description.abstract

cGMP-dependent protein kinase I (PKG I) is controlled by long-range allosteric communication between its regulatory and catalytic regions. Excessive PKG I activation contributes to several diseases, including aortopathies and inherited retinal degeneration. This thesis investigates how PKG I allostery is altered by disease-associated mutations and how the same regulatory system can be targeted for allosteric inhibition. In Chapter 2, we characterize aortic disease-related mutations at Val234 within the cyclic nucleotide-binding domain B (CNB-B) of PKG I. The variants V234I and V234A shift the conformational equilibrium of PKG I toward active-like states and increase sensitivity to cGMP, whereas V234F destabilizes the domain fold, weakening autoinhibitory interactions. Additionally, we identified position V234 as a core allosteric hub of CNB-B, highlighting its importance in PKG-related diseases. In Chapter 3, we investigate how the representative V234I and V234F substitutions rewire the CNB-B allosteric network. Both substitutions lead to an overall loss of allosteric connectivity, but V234I forms an alternative allosteric network altering the response to select cGMP analogs, whereas V234F causes a broader network disruption with no specific rewiring. In Chapter 4, we determine how a cGMP analog and lead compound for inherited retinal degeneration inhibits PKG I. CN03 stabilizes inactive-like conformations by disengaging the capping lid while relocating its binding contacts. Using a library of analogs of the lead compound, we also dissected the key drivers of allostery and the ligand anchors that dictate affinity. Together, these studies show how mutations and cyclic nucleotide analogs reshape PKG’s conformational equilibria and allosteric communication acting on the same set of critical allosteric sites. More broadly, the work presented here illustrates how covalent and non-covalent modifications modulate PKG activity, revealing general principles of allosteric control which are likely to be transferable to other kinases and signaling systems.

Degree

thesis:*
Department dc:contributor.department
Chemical Biology
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Martinez Pomier, Karla
Advisor dc:contributor.advisor
  • Melacini, Giuseppe

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Martinez Pomier, Karla. Allosteric Rewiring and Pharmacological Modulation of Protein Kinase G. 2026. https://hdl.handle.net/11375/33737